Advisorshares Psychedelics ETF (NY: PSIL )
0.9595
+0.0045
(+0.47%)
Official Closing Price
Updated: 8:00 PM EDT, Jul 5, 2024
Add to My Watchlist
All News about Advisorshares Psychedelics ETF
![](https://cdn.benzinga.com/files/images/story/2023/02/13/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/06/psyched.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/05/psychedelics-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/30/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/24/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/micheile-visual-stories-sot4-mzhyhe-unsplash_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/17/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/09/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/27/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/19/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/12/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/06/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/29/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/21/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/psyched.png?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/31/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/14/psyched.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/06/psychedelics-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/24/mackenzie-marco-xg88bydsdza-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2018/04/18/18/52/hands-3331229_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/mushroom_down_trend.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psychedelic_finance.jpg?width=720)
![](https://structurecms-production-psyclone.netdna-ssl.com/client_assets/psychedelicstockwatch/media/picture/61a9/247e/c9e6/1336/5aa7/d0c1/original_PSW_5_Best_Values.jpg?1638474877)
The Year In Review For Psychedelic Drug Stocks: 2021
December 21, 2021
Via Talk Markets
![](https://investorplace.com/wp-content/uploads/2020/06/psychedelics-1600.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_6.jpg?width=720)
![](https://cdn.pixabay.com/photo/2020/06/11/19/51/mockup-5288033_960_720.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pexels-anna-nekrashevich-6801874_4.jpg?width=720)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Subscribe Now